Precipio Management

Management Kriterienprüfungen 4/4

Precipio CEO ist Ilan Danieli , ernannt in Jun 2017, hat eine Amtszeit von 7.42 Jahren. Die jährliche Gesamtvergütung beträgt $473.44K , bestehend aus 63.4% Gehalt und 36.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.19% der Aktien des Unternehmens, im Wert von $16.86K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.4 Jahre bzw. 4.9 Jahre.

Wichtige Informationen

Ilan Danieli

Geschäftsführender

US$473.4k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	63.4%
Amtszeit als Geschäftsführer	7.4yrs
Eigentum des Geschäftsführers	0.2%
Durchschnittliche Amtszeit des Managements	7.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	4.9yrs

Jüngste Management Updates

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

Jun 07

Recent updates

Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost

Aug 21

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

Jun 07

We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation

Jun 12

Precipio shares surge on HemeScreen Anemia Panel launch

Jun 08

Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia

May 10

Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke

May 05

Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform

May 03

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ilan Danieli im Vergleich zu den Einnahmen von Precipio verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Sep 30 2024	n/a	n/a	-US$3m
Jun 30 2024	n/a	n/a	-US$4m
Mar 31 2024	n/a	n/a	-US$5m
Dec 31 2023	US$473k	US$300k	-US$6m
Sep 30 2023	n/a	n/a	-US$9m
Jun 30 2023	n/a	n/a	-US$11m
Mar 31 2023	n/a	n/a	-US$11m
Dec 31 2022	US$805k	US$300k	-US$12m
Sep 30 2022	n/a	n/a	-US$12m
Jun 30 2022	n/a	n/a	-US$11m
Mar 31 2022	n/a	n/a	-US$12m
Dec 31 2021	US$2m	US$300k	-US$9m
Sep 30 2021	n/a	n/a	-US$8m
Jun 30 2021	n/a	n/a	-US$10m
Mar 31 2021	n/a	n/a	-US$9m
Dec 31 2020	US$452k	US$261k	-US$14m
Sep 30 2020	n/a	n/a	-US$16m
Jun 30 2020	n/a	n/a	-US$14m
Mar 31 2020	n/a	n/a	-US$18m
Dec 31 2019	US$298k	US$250k	-US$13m
Sep 30 2019	n/a	n/a	-US$16m
Jun 30 2019	n/a	n/a	-US$18m
Mar 31 2019	n/a	n/a	-US$16m
Dec 31 2018	US$914k	US$250k	-US$20m
Sep 30 2018	n/a	n/a	-US$26m
Jun 30 2018	n/a	n/a	-US$33m
Mar 31 2018	n/a	n/a	-US$38m
Dec 31 2017	US$369k	US$250k	-US$33m

Vergütung im Vergleich zum Markt: IlanDie Gesamtvergütung ($USD473.44K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD650.80K).

Entschädigung vs. Einkommen: IlanDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Ilan Danieli (52 yo)

7.4yrs

Amtszeit

US$473,440

Vergütung

Mr. Ilan Danieli is the Founder of Precipio, Inc. and has been its Chief Executive Officer since June 29, 2017 and serves as its President and Director. Mr. Danieli has few years managing small and medium-...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Ilan Danieli	Founder	7.4yrs	US$473.44k	0.19% $ 16.9k
Ahmed Sabet	Chief Operating Officer	7.4yrs	US$265.34k	0.041% $ 3.6k
Ayman Mohamed	Chief Technology Officer	no data	US$284.50k	0.013% $ 1.1k
Matthew Gage	Chief Financial Officer	2.7yrs	keine Daten	keine Daten
Miri Chiko-Radomski	Chief Legal Counsel & People Officer	no data	keine Daten	keine Daten

7.4yrs

Durchschnittliche Betriebszugehörigkeit

45.5yo

Durchschnittliches Alter

Erfahrenes Management: PRPODas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.4 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Ilan Danieli	Founder	7.4yrs	US$473.44k	0.19% $ 16.9k
Kathleen LaPorte	Independent Non Executive Director	6.3yrs	US$72.81k	0.68% $ 59.5k
Richard Sandberg	Independent Chairman of the Board	4.9yrs	US$98.43k	0.0028% $ 247.9
Ronald Andrews	Independent Director	3.7yrs	US$60.81k	0.75% $ 65.8k
Christina Valauri	Director	less than a year	keine Daten	0.34% $ 29.7k
Douglas Fisher	Board Observer	less than a year	US$74.24k	0% $ 0
David Cohen	Independent Director	7yrs	US$59.73k	3.21% $ 281.1k
Jeffrey Cossman	Independent Director	7.2yrs	US$64.01k	0.83% $ 72.8k
Mark Rimer	Board Observer	3.7yrs	US$159.25k	keine Daten
Mike Makrigiorgos	Member of Scientific Advisory Board	no data	keine Daten	keine Daten
Gil Mor	Member of Scientific Advisory Board	no data	keine Daten	keine Daten

4.9yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: PRPODie Vorstandsmitglieder gelten als erfahren (4.9 Jahre durchschnittliche Amtszeit).

Precipio Management

Management Kriterienprüfungen 4/4

Wichtige Informationen

Jüngste Management Updates

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

Precipio, Inc., Annual General Meeting, Jun 13, 2024

Precipio, Inc. Announces Board Changes

Precipio, Inc. Appoints Sharon Robins as its Senior Director of Laboratory & Hospital Sales for the Product’s Division

Precipio, Inc. Welcomes Toni-Ann Mills as its Senior Director for Learning & Development

Precipio, Inc. Appoints Keith Meadors as Senior Vice President of its Products Division

Recent updates

Third quarter 2024 earnings released: US$0.42 loss per share (vs US$1.04 loss in 3Q 2023)

Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping

Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost

Second quarter 2024 earnings released: US$0.83 loss per share (vs US$1.88 loss in 2Q 2023)

New minor risk - Share price stability

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

First quarter 2024 earnings released: US$1.46 loss per share (vs US$2.61 loss in 1Q 2023)

New major risk - Financial position

Precipio, Inc., Annual General Meeting, Jun 13, 2024

Full year 2023 earnings released: US$4.51 loss per share (vs US$10.73 loss in FY 2022)

Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)

Precipio, Inc. Announces Board Changes

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity

Consensus revenue estimates increase by 11%

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

New major risk - Market cap size

New minor risk - Share price stability

Precipio, Inc.'s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

First quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2022 earnings released: US$0.54 loss per share (vs US$0.40 loss in FY 2021)

Price target decreased to US$4.00

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Precipio Receives Noncompliance Letter from the Nasdaq

Precipio, Inc. Appoints Sharon Robins as its Senior Director of Laboratory & Hospital Sales for the Product’s Division

Precipio, Inc. Launches New 1-Step Technology for All Hemescreen Assays

Second quarter 2022 earnings released: US$0.094 loss per share (vs US$0.14 loss in 2Q 2021)

Precipio, Inc. Welcomes Toni-Ann Mills as its Senior Director for Learning & Development

Forecast to breakeven in 2023

Precipio to distribute HemeScreen through Fisher Healthcare channel

Precipio, Inc. Appoints Keith Meadors as Senior Vice President of its Products Division

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Precipio Signs First IV-Cell Customer Agreement

Price target decreased to US$4.00

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Precipio, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2021

Third quarter 2021 earnings released: US$0.082 loss per share (vs US$0.21 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.14 loss per share (vs US$0.20 loss in 2Q 2020)

Precipio terminates its equity line with Lincoln Park

We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation

Precipio, Inc. Launches Hemescreen® Anemia Panel, One-Of-Its-Kind Testing Tool

Precipio shares surge on HemeScreen Anemia Panel launch

First quarter 2021 earnings released: US$0.081 loss per share (vs US$0.78 loss in 1Q 2020)

Precipio, Inc. Launches New Hemescreen Panel for AML, with an Unparalleled 4-Hour Turnaround-Time

Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia

Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke

Precipio, Inc. Launches Rapid COVID-19 Antibody Test on Amazon Platform

Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform

Price target increased to US$7.00

Precipio, Inc. to Report Q4, 2020 Results on Mar 31, 2021

Precipio, Inc. Announces Board and Committee Changes

Precipio Launches COVID-19 Antibody Testing at Point-of-Care

Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups

Precipio, Inc. Signs Sales & Marketing Agreement for HemeScreen™ with Major Oncology Distributor

Precipio & ADS Biotec Launch Seven Beta Sites for IV-Cell™

Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel

Precipio, Inc.(NasdaqCM:PRPO) dropped from Russell Microcap Value Index

Precipio, Inc.(NasdaqCM:PRPO) dropped from Russell Microcap Index

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit